Advertisement
Review Article|Articles in Press

Pathophysiology of Prediabetes, Diabetes, and Diabetic Remission in Cats

Published:March 08, 2023DOI:https://doi.org/10.1016/j.cvsm.2023.02.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. American Diabetes A. Diagnosis and classification of diabetes mellitus.
        Diabetes Care. 2013; 36: S67-S74
      2. ESVE. Project ALIVE. 30/09/2022, Available at: https://www.esve.org/alive/search.aspx. Accessed September 30, 2022.

      3. American Diabetes Association Professional Practice C. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022.
        Diabetes Care. 2022; 45: S17-S38
        • American Diabetes A.
        2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019.
        Diabetes Care. 2019; 42: S13-S28
        • Riddle M.C.
        • Cefalu W.T.
        • Evans P.H.
        • et al.
        Consensus report: definition and interpretation of remission in type 2 diabetes.
        J Clin Endocrinol Metab. 2022; 107: 1-9
        • Gostelow R.
        • Forcada Y.
        • Graves T.
        • et al.
        Systematic review of feline diabetic remission: separating fact from opinion.
        Vet J. 2014; 202: 208-221
        • Schwartz S.S.
        • Epstein S.
        • Corkey B.E.
        • et al.
        The time is right for a new classification system for diabetes: rationale and implications of the beta-cell-centric classification schema.
        Diabetes Care. 2016; 39: 179-186
        • Appleton D.J.
        • Rand J.S.
        • Sunvold G.D.
        Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain.
        J Feline Med Surg. 2001; 3: 211-228
        • Gilor C.
        • Niessen S.J.
        • Furrow E.
        • et al.
        What's in a name? Classification of diabetes mellitus in veterinary medicine and why it matters.
        J Vet Intern Med. 2016; 30: 927-940
        • Niessen S.J.
        • Church D.B.
        • Forcada Y.
        Hypersomatotropism, acromegaly, and hyperadrenocorticism and feline diabetes mellitus.
        Vet Clin North Am Small Anim Pract. 2013; 43: 319-350
        • Nelson R.W.
        • Reusch C.E.
        Animal models of disease: classification and etiology of diabetes in dogs and cats.
        J Endocrinol. 2014; 222: T1-T9
        • Osto M.
        • Zini E.
        • Reusch C.E.
        • et al.
        Diabetes from humans to cats.
        Gen Comp Endocrinol. 2013; 182: 48-53
        • Niessen S.J.
        • Forcada Y.
        • Mantis P.
        • et al.
        Studying cat (Felis catus) diabetes: beware of the acromegalic imposter.
        PLoS One. 2015; 10: e0127794
        • Valentin S.Y.
        • Cortright C.C.
        • Nelson R.W.
        • et al.
        Clinical findings, diagnostic test results, and treatment outcome in cats with spontaneous hyperadrenocorticism: 30 cases.
        J Vet Intern Med. 2014; 28: 481-487
        • Slingerland L.I.
        • Fazilova V.V.
        • Plantinga E.A.
        • et al.
        Indoor confinement and physical inactivity rather than the proportion of dry food are risk factors in the development of feline type 2 diabetes mellitus.
        Vet J. 2009; 179: 247-253
        • Zini E.
        • Lunardi F.
        • Zanetti R.
        • et al.
        Endocrine pancreas in cats with diabetes mellitus.
        Vet Pathol. 2016; 53: 136-144
        • Hall D.G.
        • Kelley L.C.
        • Gray M.L.
        • et al.
        Lymphocytic inflammation of pancreatic islets in a diabetic cat.
        J Vet Diagn Invest. 1997; 9: 98-100
        • Tuomi T.
        • Santoro N.
        • Caprio S.
        • et al.
        The many faces of diabetes: a disease with increasing heterogeneity.
        Lancet. 2014; 383: 1084-1094
        • Ohlund M.
        • Egenvall A.
        • Fall T.
        • et al.
        Environmental Risk Factors for Diabetes Mellitus in Cats.
        J Vet Intern Med. 2017; 31: 29-35
        • Narayan K.M.
        • Boyle J.P.
        • Thompson T.J.
        • et al.
        Effect of BMI on lifetime risk for diabetes in the U.S.
        Diabetes Care. 2007; 30: 1562-1566
        • Hoenig M.
        • Thomaseth K.
        • Waldron M.
        • et al.
        Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss.
        Am J Physiol Regul Integr Comp Physiol. 2007; 292: R227-R234
        • Kawano Y.
        • Nakae J.
        • Watanabe N.
        • et al.
        Colonic pro-inflammatory macrophages cause insulin resistance in an intestinal Ccl2/Ccr2-dependent manner.
        Cell Metabol. 2016; 24: 295-310
        • Rebello C.J.
        • Burton J.
        • Heiman M.
        • et al.
        Gastrointestinal microbiome modulator improves glucose tolerance in overweight and obese subjects: a randomized controlled pilot trial.
        J Diabet Complications. 2015; 29: 1272-1276
        • Williams K.J.
        • Wu X.
        Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward.
        Atherosclerosis. 2016; 247: 225-282
        • Gray S.L.
        • Donald C.
        • Jetha A.
        • et al.
        Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic beta-cell leptin signaling.
        Endocrinology. 2010; 151: 4178-4186
        • James D.E.
        • Stockli J.
        • Birnbaum M.J.
        The aetiology and molecular landscape of insulin resistance.
        Nat Rev Mol Cell Biol. 2021; 22: 751-771
        • Lebovitz H.E.
        • Banerji M.A.
        Point: visceral adiposity is causally related to insulin resistance.
        Diabetes Care. 2005; 28: 2322-2325
        • Hoenig M.
        The cat as a model for human obesity and diabetes.
        Review. Journal of diabetes science and technology. 2012; 6: 525-533
        • Samuel V.T.
        • Shulman G.I.
        The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.
        J Clin Invest. 2016; 126: 12-22
        • Wilkins C.
        • Long Jr., R.C.
        • Waldron M.
        • et al.
        Assessment of the influence of fatty acids on indices of insulin sensitivity and myocellular lipid content by use of magnetic resonance spectroscopy in cats.
        Am J Vet Res. 2004; 65: 1090-1099
        • Czech M.P.
        Insulin action and resistance in obesity and type 2 diabetes.
        Nat Med. 2017; 23: 804-814
        • Kampmann U.
        • Christensen B.
        • Nielsen T.S.
        • et al.
        GLUT4 and UBC9 protein expression is reduced in muscle from type 2 diabetic patients with severe insulin resistance.
        PLoS One. 2011; 6: e27854
        • Brennan C.L.
        • Hoenig M.
        • Ferguson D.C.
        GLUT4 but not GLUT1 expression decreases early in the development of feline obesity.
        Domest Anim Endocrinol. 2004; 26: 291-301
        • Spranger J.
        • Kroke A.
        • Mohlig M.
        • et al.
        Adiponectin and protection against type 2 diabetes mellitus.
        Lancet. 2003; 361: 226-228
        • Muranaka S.
        • Mori N.
        • Hatano Y.
        • et al.
        Obesity induced changes to plasma adiponectin concentration and cholesterol lipoprotein composition profile in cats.
        Res Vet Sci. 2011; 91: 358-361
        • Bjornvad C.R.
        • Rand J.S.
        • Tan H.Y.
        • et al.
        Obesity and sex influence insulin resistance and total and multimer adiponectin levels in adult neutered domestic shorthair client-owned cats.
        Domest Anim Endocrinol. 2014; 47: 55-64
        • Considine R.V.
        • Sinha M.K.
        • Heiman M.L.
        • et al.
        Serum immunoreactive-leptin concentrations in normal-weight and obese humans.
        N Engl J Med. 1996; 334: 292-295
        • Freitas Lima L.C.
        • Braga V.A.
        • do Socorro de Franca Silva M.
        • et al.
        Adipokines, diabetes and atherosclerosis: an inflammatory association.
        Front Physiol. 2015; 6: 304
        • Park H.K.
        • Ahima R.S.
        Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism.
        Metabolism. 2015; 64: 24-34
        • Feinstein R.
        • Kanety H.
        • Papa M.Z.
        • et al.
        Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.
        J Biol Chem. 1993; 268: 26055-26058
        • Hoenig M.
        • McGoldrick J.B.
        • deBeer M.
        • et al.
        Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats.
        Domest Anim Endocrinol. 2006; 30: 333-344
        • Hoenig M.
        • Pach N.
        • Thomaseth K.
        • et al.
        Cats differ from other species in their cytokine and antioxidant enzyme response when developing obesity.
        Obesity. 2013; 21: E407-E414
        • Tvarijonaviciute A.
        • Ceron J.J.
        • Holden S.L.
        • et al.
        Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis. Research Support, Non-U.S. Gov't.
        Domest Anim Endocrinol. 2012; 42: 129-141
        • Bensellam M.
        • Laybutt D.R.
        • Jonas J.C.
        The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions.
        Mol Cell Endocrinol. 2012; 364: 1-27
        • Zini E.
        • Osto M.
        • Franchini M.
        • et al.
        Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat.
        Diabetologia. 2009; 52: 336-346
        • Brunzell J.D.
        • Robertson R.P.
        • Lerner R.L.
        • et al.
        Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests.
        J Clin Endocrinol Metab. 1976; 42: 222-229
        • Ritzel R.A.
        • Hansen J.B.
        • Veldhuis J.D.
        • et al.
        Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
        J Clin Endocrinol Metab. 2004; 89: 795-805
        • Oslowski C.M.
        • Urano F.
        A switch from life to death in endoplasmic reticulum stressed beta-cells.
        Diabetes Obes Metab. 2010; 12 (0 2): 58-65
        • DeFronzo R.A.
        Dysfunctional fat cells, lipotoxicity and type 2 diabetes.
        Int J Clin Pract Suppl. 2004; : 9-21https://doi.org/10.1111/j.1368-504x.2004.00389.x
        • Poitout V.
        • Robertson R.P.
        Glucolipotoxicity: fuel excess and beta-cell dysfunction.
        Endocr Rev. 2008; 29: 351-366
        • Poitout V.
        • Amyot J.
        • Semache M.
        • et al.
        Glucolipotoxicity of the pancreatic beta cell.
        Biochim Biophys Acta. 2010; 1801: 289-298
        • Nishi M.
        • Sanke T.
        • Nagamatsu S.
        • et al.
        Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits.
        J Biol Chem. 1990; 265: 4173-4176
        • Ahmad E.
        • Ahmad A.
        • Singh S.
        • et al.
        A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes.
        Biochimie. 2011; 93: 793-805
        • Rafacho A.
        • Ortsater H.
        • Nadal A.
        • et al.
        Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes.
        J Endocrinol. 2014; 223: R49-R62
        • Woolcock A.D.
        • Bugbee A.C.
        • Creevy K.E.
        Evaluation of baseline cortisol concentration to monitor efficacy of twice-daily administration of trilostane to dogs with pituitary-dependent hyperadrenocorticism: 22 cases (2008-2012).
        J Am Vet Med Assoc. 2016; 248: 814-821
        • Schaefer S.
        • Kooistra H.S.
        • Riond B.
        • et al.
        Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands.
        J Feline Med Surg. 2017; 19: 888-896
        • Zini E.
        • Hafner M.
        • Kook P.
        • et al.
        Longitudinal evaluation of serum pancreatic enzymes and ultrasonographic findings in diabetic cats without clinically relevant pancreatitis at diagnosis.
        J Vet Intern Med. 2015; 29: 589-596
        • Almgren P.
        • Lehtovirta M.
        • Isomaa B.
        • et al.
        Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study.
        Diabetologia. 2011; 54: 2811-2819
        • O'Neill D.G.
        • Gostelow R.
        • Orme C.
        • et al.
        Epidemiology of diabetes mellitus among 193,435 cats attending primary-care veterinary practices in England.
        J Vet Intern Med. 2016; 30: 964-972
        • Ohlund M.
        • Fall T.
        • Strom Holst B.
        • et al.
        Incidence of Diabetes Mellitus in Insured Swedish Cats in Relation to Age, Breed and Sex.
        J Vet Intern Med. 2015; 29: 1342-1347
        • Rand J.S.
        • Bobbermien L.M.
        • Hendrikz J.K.
        • et al.
        Over representation of Burmese cats with diabetes mellitus.
        Aust Vet J. 1997; 75: 402-405
        • Prahl A.
        • Guptill L.
        • Glickman N.W.
        • et al.
        Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals.
        J Feline Med Surg. 2007; 9: 351-358
        • Alhaddad H.
        • Khan R.
        • Grahn R.A.
        • et al.
        Extent of linkage disequilibrium in the domestic cat, Felis silvestris catus, and its breeds.
        PLoS One. 2013; 8: e53537
        • O'Leary C.A.
        • Duffy D.L.
        • Gething M.A.
        • et al.
        Investigation of diabetes mellitus in Burmese cats as an inherited trait: a preliminary study.
        N Z Vet J. 2013; 61: 354-358
        • Kurushima J.D.
        • Lipinski M.J.
        • Gandolfi B.
        • et al.
        Variation of cats under domestication: genetic assignment of domestic cats to breeds and worldwide random-bred populations.
        Anim Genet. 2013; 44: 311-324
        • Forcada Y.
        • Holder A.
        • Church D.B.
        • et al.
        A polymorphism in the melanocortin 4 receptor gene (MC4R:c.92C>T) is associated with diabetes mellitus in overweight domestic shorthaired cats.
        J Vet Intern Med. 2014; 28: 458-464
        • Xi B.
        • Chandak G.R.
        • Shen Y.
        • et al.
        Association between common polymorphism near the MC4R gene and obesity risk: a systematic review and meta-analysis.
        PLoS One. 2012; 7: e45731
        • Forcada Y.
        • Boursnell M.
        • Catchpole B.
        • et al.
        A genome-wide association study identifies novel candidate genes for susceptibility to diabetes mellitus in non-obese cats.
        PLoS One. 2021; 16: e0259939
        • Samaha G.
        • Wade C.M.
        • Beatty J.
        • et al.
        Mapping the genetic basis of diabetes mellitus in the Australian Burmese cat (Felis catus).
        Sci Rep. 2020; 10: 19194
        • Balmer L.
        • O'Leary C.A.
        • Menotti-Raymond M.
        • et al.
        Mapping of Diabetes Susceptibility Loci in a Domestic Cat Breed with an Unusually High Incidence of Diabetes Mellitus.
        Genes. 2020; 11https://doi.org/10.3390/genes11111369
        • Bird S.R.
        • Hawley J.A.
        Update on the effects of physical activity on insulin sensitivity in humans.
        BMJ Open Sport Exerc Med. 2016; 2: e000143
        • Panciera D.L.
        • Thomas C.B.
        • Eicker S.W.
        • et al.
        Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986).
        J Am Vet Med Assoc. 1990; 197: 1504-1508
        • Chiu K.C.
        • Lee N.P.
        • Cohan P.
        • et al.
        Beta cell function declines with age in glucose tolerant Caucasians.
        Clin Endocrinol. 2000; 53: 569-575
        • Lederer R.
        • Rand J.S.
        • Jonsson N.N.
        • et al.
        Frequency of feline diabetes mellitus and breed predisposition in domestic cats in Australia.
        Vet J. 2009; 179: 254-258
        • Lowe A.D.
        • Graves T.K.
        • Campbell K.L.
        • et al.
        A pilot study comparing the diabetogenic effects of dexamethasone and prednisolone in cats. Comparative Study Research Support, Non-U.S. Gov't.
        J Am Anim Hosp Assoc. Sep-Oct 2009; 45: 215-224
        • Frezoulis P.S.
        • Oikonomidis I.L.
        • Saridomichelakis M.N.
        • et al.
        Prevalence, association with systemic inflammatory response syndrome and outcome of stress hyperglycaemia in sick cats.
        J Small Anim Pract. 2022; 63: 197-202
      4. Reusch C. Feline diabetes mellitus. In: Feldman EC, Nelson RW, Reusch C, et al. Canine and feline endocrinology, 4th edition, 2015, Elsevier Saunders, St. Louis, MO, 258–314, chap 7.

        • Reeve-Johnson M.K.
        • Rand J.S.
        • Vankan D.
        • et al.
        Cutpoints for screening blood glucose concentrations in healthy senior cats.
        J Feline Med Surg. 2017; 19: 1181-1191
        • Reeve-Johnson M.K.
        • Rand J.S.
        • Vankan D.
        • et al.
        Diagnosis of prediabetes in cats: glucose concentration cut points for impaired fasting glucose and impaired glucose tolerance.
        Domest Anim Endocrinol. 2016; 57: 55-62
        • Hoenig M.
        Comparative aspects of human, canine, and feline obesity and factors predicting progression to diabetes.
        Veterinary Sciences. 2014; 1: 121-135
        • Holst J.J.
        • Gromada J.
        Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.
        Am J Physiol Endocrinol Metab. 2004; 287: E199-E206
        • Kim W.
        • Egan J.M.
        The role of incretins in glucose homeostasis and diabetes treatment.
        Pharmacol Rev. 2008; 60: 470-512
        • Gilor C.
        • Graves T.K.
        • Gilor S.
        • et al.
        The incretin effect in cats: comparison between oral glucose, lipids, and amino acids. Research Support, Non-U.S. Gov't.
        Domest Anim Endocrinol. 2011; 40: 205-212
        • Nauck M.A.
        • Bartels E.
        • Orskov C.
        • et al.
        Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
        J Clin Endocrinol Metab. 1993; 76: 912-917
        • Li X.
        • Li W.
        • Wang H.
        • et al.
        Pseudogenization of a sweet-receptor gene accounts for cats' indifference toward sugar.
        PLoS Genet. 2005; 1: 27-35
        • Hoenig M.
        • Jordan E.T.
        • Ferguson D.C.
        • et al.
        Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats.
        Domest Anim Endocrinol. 2010; 38: 95-102
        • Gilor C.
        • Graves T.K.
        • Lascelles B.D.
        • et al.
        The effects of body weight, body condition score, sex, and age on serum fructosamine concentrations in clinically healthy cats.
        Vet Clin Pathol. 2010; 39: 322-328
        • Hoenig M.
        • Traas A.M.
        • Schaeffer D.J.
        Evaluation of routine hematology profile results and fructosamine, thyroxine, insulin, and proinsulin concentrations in lean, overweight, obese, and diabetic cats.
        J Am Vet Med Assoc. 2013; 243: 1302-1309
        • Suleiman M.
        • Marselli L.
        • Cnop M.
        • et al.
        The Role of Beta Cell Recovery in Type 2 Diabetes Remission.
        Int J Mol Sci. 2022; 23https://doi.org/10.3390/ijms23137435
        • Nelson R.W.
        • Griffey S.M.
        • Feldman E.C.
        • et al.
        Transient clinical diabetes mellitus in cats: 10 cases (1989-1991).
        J Vet Intern Med. 1999; 13: 28-35
        • Tschuor F.
        • Zini E.
        • Schellenberg S.
        • et al.
        Remission of diabetes mellitus in cats cannot be predicted by the arginine stimulation test. Research Support, Non-U.S. Gov't.
        J Vet Intern Med. 2011; 25: 83-89
        • Roomp K.
        • Rand J.
        Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine.
        J Feline Med Surg. 2009; 11: 668-682
        • Marshall R.D.
        • Rand J.S.
        • Morton J.M.
        Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins. Clinical Trial Research Support, Non-U.S. Gov't.
        J Feline Med Surg. 2009; 11: 683-691
        • Sparkes A.H.
        • Cannon M.
        • Church D.
        • et al.
        ISFM consensus guidelines on the practical management of diabetes mellitus in cats.
        J Feline Med Surg. 2015; 17: 235-250
        • Niessen S.
        • Voth R.
        • Kroh C.
        • et al.
        Once daily oral therapy for feline diabetes mellitus: SGLT-2-inhibitor velagliflozin as stand-alone therapy compared to insulin injection therapy in diabetic cats [abstract].
        J Vet Intern Med. 2022; 36: 2512-2513
        • Roomp K.
        • Rand J.
        Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.
        J Feline Med Surg. 2012; 14: 566-572
        • Bennett N.
        • Greco D.S.
        • Peterson M.E.
        • et al.
        Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus. Comparative Study Controlled Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't.
        J Feline Med Surg. 2006; 8: 73-84
        • Marshall R.D.
        • Rand J.S.
        • Morton J.M.
        Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats. Comparative Study Research Support, Non-U.S. Gov't.
        J Vet Pharmacol Therapeut. 2008; 31: 205-212
        • Gilor C.
        • Ridge T.K.
        • Attermeier K.J.
        • et al.
        Pharmacodynamics of insulin detemir and insulin glargine assessed by an isoglycemic clamp method in healthy cats. Randomized Controlled Trial Research Support, Non-U.S. Gov't.
        J Vet Intern Med. 2010; 24: 870-874
        • Gostelow R.
        • Scudder C.
        • Forcada Y.
        • et al.
        One year, prospective, randomized trial comparing efficacy of glargine and protamine zinc insulins in diabetic cats [abstract].
        J Vet Intern Med. 2017; 31: 1273
        • Farrow H.A.
        • Rand J.S.
        • Morton J.M.
        • et al.
        Effect of dietary carbohydrate, fat, and protein on postprandial glycemia and energy intake in cats.
        J Vet Intern Med. 2013; 27: 1121-1135
        • Mazzaferro E.M.
        • Greco D.S.
        • Turner A.S.
        • et al.
        Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
        J Feline Med Surg. 2003; 5: 183-189
        • Fenn J.
        • Kenny P.J.
        • Scudder C.J.
        • et al.
        Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.
        J Vet Intern Med. 2021; 35: 823-833
        • van Bokhorst K.L.
        • Galac S.
        • Kooistra H.S.
        • et al.
        Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.
        J Vet Intern Med. 2021; 35: 834-842
        • Gostelow R.
        • O'Neill D.G.
        • Brodbelt D.C.
        • et al.
        Diabetic remission in cats examined in UK primary-care practices: Occurrence and risk factors (abstract).
        J Vet Intern Med. 2017; 31: 1273
        • Gottlieb S.
        • Rand J.S.
        • Marshall R.
        • et al.
        Glycemic status and predictors of relapse for diabetic cats in remission.
        J Vet Intern Med. 2015; 29: 184-192
        • Zini E.
        • Hafner M.
        • Osto M.
        • et al.
        Predictors of clinical remission in cats with diabetes mellitus.
        J Vet Intern Med. 2010; 24: 1314-1321
        • World Health Organization
        Definition of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. WHO Document Production Services, Geneva, Switzerland2006
        • Nerhagen S.
        • Moberg H.L.
        • Boge G.S.
        • et al.
        Prednisolone-induced diabetes mellitus in the cat: a historical cohort.
        J Feline Med Surg. 2021; 23: 175-180
        • Lee P.
        • Mori A.
        • Coradini M.
        • et al.
        Potential predictive biomarkers of obesity in Burmese cats.
        Vet J. 2013; 195: 221-227